Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therapix Biosciences Ltd ADR TRPXY

Therapix Biosciences Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several innovative immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The operating segments of the group are Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the Company's operation); and Pain clinic


OTCPK:TRPXY - Post by User

Comment by Fundy13on Jan 09, 2019 12:59pm
42 Views
Post# 29206961

RE:RE:HUGE

RE:RE:HUGEI agree, but you have to think at the very minimum HUGE would have kept the 130million share offer.  They were comfortable giving up a certain percentage of the company based on the 130million shares, it was when share price dropped and they would have to give up more shares that they had issues.  130million shares at $.40 would be about 80% of what the original LOI offered.  You would think they could find middle ground in HUGE AP stays in this range or increases.  The big mistake HUGE made was agreeing to the share being issued at the 20 day moving average, they should have set the price a the time the agreement was signed.
Pretty sure IF they moved forward the LOI stage woudl be skipped and they would go straight to a difinitive agreement so seting the SP at time of signing would be wise.
<< Previous
Bullboard Posts
Next >>